The role of nitric oxide in lung innate immunity: Modulation by surfactant protein-A

Molecular and Cellular Biochemistry

Volumn 234-235, Issue , 2002, Pages 39-48

  O'Reilly, Philip ^a   Hickman Davis, Judy M ^a   McArdle, Philip ^a   Young, K Randall ^a   Matalon, Sadis ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Lung innate immunity; Nitric oxide; Surfactant protein A

Indexed keywords

NITRIC OXIDE; NITROGEN; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SURFACTANT PROTEIN A; REACTIVE NITROGEN SPECIES;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CHEMICAL REACTION; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNITY; IMMUNOMODULATION; INHIBITION KINETICS; KLEBSIELLA PNEUMONIAE; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; LUNG INFECTION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PNEUMONIA; RAT; ANIMAL; BACTERIUM; DRUG EFFECT; IMMUNOLOGY; INNATE IMMUNITY; LUNG; MACROPHAGE; METABOLISM; PATHOGENICITY; TRANSGENIC MOUSE;

ANIMAL; BACTERIA; HUMAN; IMMUNITY, NATURAL; KLEBSIELLA PNEUMONIAE; LUNG; MACROPHAGES; MICE; MICE, TRANSGENIC; NITRIC OXIDE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; REACTIVE NITROGEN SPECIES; SUPEROXIDES; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; HUMANS;

EID: 4243668103     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015996424256     Document Type: Article

References (109)

1. Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice
2. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: Elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival
3. Collectins and pulmonary host defense
4. Surfactant proteins a and d and pulmonary host defense
5. Immunomodulatory functions of surfactant
6. Collectin structure: A review
7. Pulmonary surfactant proteins
8. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages
9. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite
10. SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages
11. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages
12. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages
13. Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa
14. Rat surfactant protein D enhances the production of oxygen radicals by rat alveolar macrophages
15. Surfactant protein A modulates release of reactive oxygen species from alveolar macrophages
16. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production
17. Surfactant protein A regulates cytokine production in the monocytic cell line THP-1
18. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage
19. Surfactant proteins A and D specifically stimulate directed actin-based responses in alveolar macrophages
20. Surfactant protein A differentially regulates IFN-gamma- and LPS-induced nitrite production by rat alveolar macrophages
21. Surfactant protein A-deficient mice are susceptible to group B streptococal infection
22. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection
23. Perspectives series: Host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity
24. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens
25. Nitric oxide: Physiology, pathophysiology, and pharmacology
26. Nitric oxide and its role in the cardiovascular system
27. The interplay of nitric oxide and peroxynitrite with signal transduction pathways: Implications for disease
28. Nitric oxide and the immune response
29. Inducible nitric oxide synthase in human diseases
30. NO inhibitions: Antimicrobial properties of nitric oxide
31. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine
32. Surfactant protein A and nitric oxide-mediated mechanisms of Klebsiella pneumoniae killing by human alveolar macrophages
33. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase
34. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis
35. Nitric oxide in Tanzanian children with malaria: Inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression
36. Nitric oxide production in murine leishmaniasis: Correlation of progressive infection with increasing systemic synthesis of nitric oxide
37. Nitrogen oxide levels in patients after trauma and during sepsis
38. Effects of aminoguanidine on latent murine tuberculosis
39. Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae
40. Inducible nitric oxide synthase: What difference does it make?
41. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity
42. Identification of nitric oxide synthase as a protective locus against tuberculosis
43. Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice
44. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene
45. Lung surfactant and reactive oxygen-nitrogen species: Antimicrobial activity and host-pathogen interactions
46. Oxygen radical-nitric oxide reactions in vascular diseases
47. Nitric oxide and intracellular heme
48. A novel reaction mechanism for the formation of S-nitrosothiol in vivo
49. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli
50. Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi
51. Peroxynitrite contributes to the candidacidal activity of nitric oxide-producing macrophages
52. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli
53. Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model
54. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways
55. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification
56. Cyclophosphamide decreases nitrotyrosine formation and inhibits nitric oxide production by alveolar macrophages in mycoplasmosis
57. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro
58. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo
59. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase
60. Oxygen-dependent anti-Salmonella activity of macrophages
61. Diffusion of peroxynitrite across erythrocyte membranes
62. Peptide transport and chemotaxis in Escherichia coli and Salmonella typhimurium: Characterization of the dipeptide permease (Dpp) and the dipeptide-binding protein
63. Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells
64. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors
65. Peroxynitrite-mediated oxidative protein modifications
66. Superoxide and peroxynitrite inactive aconitases, but nitric oxide does not
67. S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups
68. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria
69. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives
70. Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein/thionein
71. NO running on MT: Regulation of zinc homeostasis by interaction of nitric oxide with metallothionein
72. Visualization of labile zinc and its role in apoptosis of primary airway epithelial cells and cell lines
73. Role of zinc in pulmonary endothelial cell response to oxidative stress
74. Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis
75. Zn(2+) induces permeability transition pore opening and release of pro-apoptotic peptides from neuronal mitochondria
76. The role of zinc in selective neuronal death after transient global cerebral ischemia
77. Pyrrolidine dithiocarbamate induces bovine cerebral endothelial cell death by increasing the intracellular zinc level
78. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major
79. Role of nitric oxide and superoxide in Giardia lamblia killing
80. Mycobacteriocidal action of exogenous nitric oxide
81. Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion
82. Nitric oxide as an antioxidant
83. Attenuation of p47phox and p67phox membrane translocation as the inhibitory mechanism of S-nitrosothiol on the respiratory burst oxidase in human neutrophils
84. The role of nitric oxide in innate immunity
85. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity
86. Modulation of nitric oxide production by lung surfactant in alveolar macrophages
87. Nitric oxide production by rat alveolar macrophages can be modulated in vitro by surfactant protein A
88. SP-A enhances uptake of bacillus Calmette-Guerin by macrophages through a specific SP-A receptor
89. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14
90. Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis
91. Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production
92. Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production
93. Human surfactant protein a suppresses T cell-dependent inflammation and attenuates the manifestations of idiopathic pneumonia syndrome in mice
94. Surfactant protein A: Regulation of innate and adaptive immune responses in lung inflammation
95. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo
96. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo
97. Expression of inducible nitric oxide synthase and formation of nitric oxide by alveolar macrophages: An interspecies comparison
98. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome
99. Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction
100. Expression of inducible-NOS in human glomerulonephritis: The possible source is infiltrating monocytes/macrophages
101. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients
102. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer
103. Release of reactive oxygen and nitrogen intermediates from monocytes of patients with pulmonary tuberculosis
104. Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB
105. The role of nitric oxide in the immune response of tuberculosis
106. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen
107. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages
108. Bacterial infection induces nitric oxide synthase in human neutrophils
109. Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide